MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by PROVERBIO, F.
Right arrow Articles by RAWLINS, F. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by PROVERBIO, F.
Right arrow Articles by RAWLINS, F. A.

Molecular Pharmacology, Vol 14, 911-919, Copyright © 1978 by the American Society for Pharmacology and Experimental Therapeutics

Increment in Sodium and Potassium Dependent Adenosine Triphosphatase of Brain Microsomal Fraction from Rats Treated with the Cholesterol Biosynthesis Inhibitor AY 9944

F. PROVERBIO 1 and F. A. RAWLINS 1

1 Centro de Biofisica y Bioquímica, Instituto Venezolano de Investigaciones CientIficas (IVIC), Apartado 1827, Caracas 101, Venezuela

Na+, K+-ATPase activity of brain microsomal fractions prepared from rats treated with the cholesterol biosynthesis inhibitor AY 9944 was found to be markedly increased when compared with nontreated control fractions. Both control and AY 9944-treated preparations increase their Na+, K+-ATPase activity with increasing temperatures; such increments were higher in the microsomal fractions prepared from the AY 9944-treated rats than those from the untreated controls. The apparent Km calculated for Na+, K+ and Mg2+, as well as the optimal ratio Mg2+/ATP of the Na+, K+-ATPase from both microsomal fractions, were found to be the same in each case. The binding of [3H]-ouabain as a function of time, as well as a function of the incubation temperature, was also the same in both preparations. If it is considered that treatment with AY 9944 results in the partial substitution of cholesterol by 7-dehydrocholesterol without modifying any other constituent in the microsomal membranes, the observed increment in the Na+, K+-ATPase activity could be interpreted as the result of an increased membrane "fluidity" and shows that Na+, K+-ATPase activity is dependent upon the environmental sterol composition.

Note:
ACKNOWLEDGMENTS The authors are grateful for the stimulating criticism of Dr. Joseph Hoffmann, the excellent technical assistance of Mrs. T. Proverbio and the efficient secretarial help of Mrs. Consuelo Vargas. The drug AY 9944 was kindly supplied by Dr. D. Dvornik from Ayerst Laboratories, Montreal.

Submitted on December 15, 1977
Accepted on April 13, 1978




This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
A. Achour, J.-C. Landureau, R. Salerno-Concalves, J.-C. Mazière, and D. Zagury
Restoration of Immune Response by a Cationic Amphiphilic Drug (AY 9944) In Vitro: A New Approach To Chemotherapy against Human Immunodeficiency Virus Type 1
Antimicrob. Agents Chemother., October 1, 1998; 42(10): 2482 - 2491.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1978 by the American Society for Pharmacology and Experimental Therapeutics